Tetraneuron

Presence & Recognition

Tetraneuron is attending Advanced Therapies Europe 2026 in Barcelona, organised by Phacilitate, with Angel Lucio Pereira, Cristina Sánchez-Puelles, and Hélène Panier joining leaders from the advanced therapies and regenerative medicine community.

Reported by Tetraneuron

Capital & Finance

Tetraneuron has received public funding totaling over 4.3 million euros for its projects in collaboration with the Ministry of Science and Innovation of Spain.

Reported by Tetraneuron

Capital & Finance

Tetraneuron received more than €3 million to support preparatory work for the clinical development of its Alzheimer's disease programme in Spain in collaboration with HM Hospitales and Fundación CIEN.

Reported by Tetraneuron

Capital & Finance

Tetraneuron received a second grant of more than €1.3 million to support the development of its Parkinson's disease programme in collaboration with the University of Navarra.

Reported by Tetraneuron

Capital & Finance

Tetraneuron has been awarded two new public grants totalling more than €4.3 million to advance its gene therapy programmes in Alzheimer's disease and Parkinson's disease.

Reported by Tetraneuron

Presence & Recognition

Tetraneuron was featured in El Mundo.

Reported by Angel Lucio

Presence & Recognition

Tetraneuron will attend Advanced Therapies Europe 2026 organised by Phacilitate from 7 to 9 September at the InterContinental Barcelona.

Reported by Tetraneuron

Presence & Recognition

Tetraneuron employees Angel Lucio, Hélène Panier, and Cristina Sánchez-Puelles are returning to Barcelona to participate in an ATMP ecosystem project.

Reported by Angel Lucio